510(k) Report

FDA product code · Clinical chemistry

Test, Immunoassay, Biosensor, Hcg

NALClass II21 CFR 862.1155510(k) required2 decisions since 19990 recalls

2 FDA decisions since 1999. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, clinical chemistry panel

Twenty years of NAL at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · NAL

FDA has decided no NAL device since 2007.

Median 510(k) review, days · NAL

Too few NAL 510(k)s in any year since 2007 to give a median.

Recalls per year · NAL

No recall names NAL since 2007.

Adverse event reports per year · NAL

12in 2016

2010: 32015: 12016: 12
2007high 12 (2016) · low 0 (2007)2025

MAUDE reports naming product code NAL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—03
20110—00
20120—00
20130—00
20140—00
20150—01
20160—012
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
FIG. 1 — NAL by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in NAL? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 862.1155.